Back | Next |
home / stock / abt / abt message board
Subject | By | Source | When |
---|---|---|---|
$ABT 2Q22 CC transcript: | DewDiligence | investorshub | 07/20/2022 4:54:05 PM |
$ABT 2Q22 Results by Business Segment | DewDiligence | investorshub | 07/20/2022 4:49:57 PM |
$ABT reports 2Q22 resultsraises 2022 EPS guidance: | DewDiligence | investorshub | 07/20/2022 11:58:11 AM |
Should be $150+ | wiwineguy | investorshub | 07/16/2022 12:41:51 AM |
FDA approves $ABTs Freestyle Libre 3the most advanced | DewDiligence | investorshub | 05/31/2022 4:09:16 PM |
$ABT is developing a monkeypox diagnostic: | DewDiligence | investorshub | 05/26/2022 10:47:38 PM |
should be $140 | NOLA1961 | investorshub | 05/18/2022 1:11:10 PM |
$ABT $120 TARGET PRICE TODAY | weedtrader420 | investorshub | 05/17/2022 11:23:34 AM |
It was hit pretty hard in February, when | DewDiligence | investorshub | 05/13/2022 3:09:53 PM |
Surprised the stock wasn't hit massively......... | Termite7 | investorshub | 05/13/2022 1:50:21 PM |
$ABT infant-formula plant expected back online soon: | DewDiligence | investorshub | 05/11/2022 9:37:24 PM |
Thanks. Was looking for a non Seeking alpha source | Hunting_for_multiples | investorshub | 04/22/2022 1:32:06 AM |
1Q22 FreeStyle Libre sales were $1.0B (yes, a | DewDiligence | investorshub | 04/20/2022 10:00:32 PM |
$ABT 1Q22 CC transcript: | DewDiligence | investorshub | 04/20/2022 9:28:12 PM |
$ABT 1Q22 Results by Business Segment | DewDiligence | investorshub | 04/20/2022 4:57:11 PM |
$ABT sold $3.3B of COVID diagnostics in 1Q22: | DewDiligence | investorshub | 04/20/2022 2:49:15 PM |
CDC unable to link infant-formula contamination to $ABTs manufacturing plant: | DewDiligence | investorshub | 04/18/2022 3:08:21 PM |
$ABT fell 6% cumulatively on Thu/Fri due to infant-formula recall: | DewDiligence | investorshub | 02/21/2022 5:47:18 PM |
$ABT 4Q21 CC transcript: | DewDiligence | investorshub | 01/27/2022 12:48:13 AM |
$ABT 4Q21 Results by Business Segment | DewDiligence | investorshub | 01/26/2022 5:18:35 PM |
News, Short Squeeze, Breakout and More Instantly...
Abbott Laboratories Company Name:
ABT Stock Symbol:
NYSE Market:
Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee PR Newswire More than 20 million people in the U.S. are living with peripheral artery disease (PAD) yet there have been limited treatment options The first-of-its-kind Esprit™ B...
2024-04-28 07:45:00 ET Finding "forever" stocks isn't easy. Corporations that can thrive and pay dividends for long periods are rare, but they do exist. Such companies tend to have several qualities, including competitive advantages and leadership in industries that are likely to continue g...
NORTHAMPTON, MA / ACCESSWIRE / April 23, 2024 / Abbott Eleven new HeartMates with 11 inspiring stories recognized at Abbott HeartMates Draft Day event in NYC. Abbott Just a week before the pro football draft, Abbott held a high-profile draft day experience for our HeartMates program. Hos...